Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid

被引：68

作者：

Babcock, HM

Ritchie, DJ

Christiansen, E

Starlin, R

Little, R

Stanley, S

机构：

[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA

[2] Barnes Jewish Hosp, St Louis, MO 63110 USA

[3] St Louis Coll Pharm, St Louis, MO USA

来源：

CLINICAL INFECTIOUS DISEASES | 2001年 / 32卷 / 09期

关键词：

D O I：

10.1086/319986

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report a case of vancomycin-resistant Enterococcus faecium endocarditis that failed to respond to sequential monotherapy with chloramphenicol and quinupristin/dalfopristin but was successfully treated with oral linezolid.

引用

页码：1373 / 1375

页数：3

共 9 条

[1] Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci
Bostic, GD
Perri, MB
Thal, LA
Zervos, MJ
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) : 109 - 112
[2] Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections
Chien, JW
Kucia, ML
Salata, RA
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 146 - 151
[3] Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to Enterococci with VanA/VanB resistance patterns
Furlong, WB
Rakowski, TA
[J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) : 163 - 164
[4] Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia
Garbutt, JM
Ventrapragada, M
Littenberg, B
Mundy, LM
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 466 - 472
[5] Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds
Jones, RN
Low, DE
Pfaller, MA
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) : 101 - 112
[6] Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin:: A synergistic drug combination
Matsumura, S
Simor, AE
[J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) : 1554 - 1556
[7] Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin)
McNeil, SA
Clark, NM
Chandrasekar, PH
Kauffman, CA
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) : 403 - 404
[8] Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin
Noskin, GA
Siddiqui, F
Stosor, V
Kruzynski, J
Peterson, LR
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) : 689 - 690
[9] Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium
Rybak, MJ
Cappelletty, DM
Moldovan, T
Aeschlimann, JR
Kaatz, GW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 721 - 724

← 1 →